Positive long-term outcomes from sustained glatiramer treatment of MS
Follow-up of multiple sclerosis patients treated for 10 years with glatiramer acetate suggests it is possible to achieve both short- and long-term benefits from therapy, according to a recent review....
Want to read complete article? Please Sign in or Register.